T2 Biosystems is a diagnostics & research business based in the US. T2 Biosystems shares (TTOO) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.12 – a decrease of 6.4% over the previous week. T2 Biosystems employs 113 staff and has a trailing 12-month revenue of around $7.2 million.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – TTOO.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy T2 Biosystems stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
T2 Biosystems stock price (PINK: TTOO)
Use our graph to track the performance of TTOO stocks over time.
Historical closes compared with the close of $0.117 from 2025-03-21
1 week (2025-03-14)
-6.40%
1 month (2025-02-24)
7.93%
3 months (2024-12-24)
-66.09%
6 months (2024-09-24)
-94.29%
1 year (2024-03-22)
-95.92%
2 years (2023-03-23)
-99.77%
3 years (2022-03-23)
2164
5 years (2020-03-23)
1987
T2 Biosystems financials
Revenue TTM
$7.2 million
Gross profit TTM
$-24,766,000
Return on assets TTM
-90.46%
Return on equity TTM
-622.14%
Profit margin
0%
Book value
$-6.91
Market Capitalization
$10.5 million
TTM: trailing 12 months
T2 Biosystems share dividends
We're not expecting T2 Biosystems to pay a dividend over the next 12 months.
Have T2 Biosystems's shares ever split?
T2 Biosystems's shares were
split on a 1:100 basis on 12 October 2023
. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your T2 Biosystems shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for T2 Biosystems shares which in turn could have impacted T2 Biosystems's share price.
T2 Biosystems share price volatility
Over the last 12 months, T2 Biosystems's shares have ranged in value from as little as $0.056 up to $6.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while T2 Biosystems's is 0.376. This would suggest that T2 Biosystems's shares are less volatile than average (for this exchange).
T2 Biosystems overview
T2 Biosystems, Inc. , an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Frequently asked questions
What percentage of T2 Biosystems is owned by insiders or institutions? Currently 10.168% of T2 Biosystems shares are held by insiders and 73.513% by institutions.How many people work for T2 Biosystems? Latest data suggests 113 work at T2 Biosystems.When does the fiscal year end for T2 Biosystems? T2 Biosystems's fiscal year ends in December.Where is T2 Biosystems based? T2 Biosystems's address is: 101 Hartwell Avenue, Lexington, MA, United States, 02421What is T2 Biosystems's ISIN number? T2 Biosystems's international securities identification number is: US89853L1044What is T2 Biosystems's CUSIP number? T2 Biosystems's Committee on Uniform Securities Identification Procedures number is: 89853L104
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
